Low-Grade Central Osteosarcoma Clinical Presentation

1. Rougraff BT. Variants of osteosarcoma. Curr Opin Orthop. 1999. 10:485-90.

2. Kenan S, Ginat DT, Steiner GC. Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula. Skeletal Radiol. 2007 Apr. 36 (4):347-51. [QxMD MEDLINE Link].

3. Franceschina MJ, Hankin RC, Irwin RB. Low-grade central osteosarcoma resembling fibrous dysplasia. A report of two cases. Am J Orthop (Belle Mead NJ). 1997 Jun. 26 (6):432-40. [QxMD MEDLINE Link].

4. Broders AC, Hargrave R, Meyerding HW. Pathological features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet. 1939. 69:267.

5. Park HR, Jung WW, Bacchini P, Bertoni F, Kim YW, Park YK. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma. Pathol Res Pract. 2006. 202 (7):509-15. [QxMD MEDLINE Link].

6. Kumar A, Varshney MK, Khan SA, Rastogi S, Safaya R. Low grade central osteosarcoma--a diagnostic dilemma. Joint Bone Spine. 2008 Oct. 75 (5):613-5. [QxMD MEDLINE Link].

7. Muramatsu K, Hashimoto T, Seto S, Gondo T, Ihara K, Taguchi T. Low-grade central osteosarcoma mimicking fibrous dysplasia: a report of two cases. Arch Orthop Trauma Surg. 2008 Jan. 128 (1):11-5. [QxMD MEDLINE Link].

8. Choong PF, Pritchard DJ, Rock MG, Sim FH, McLeod RA, Unni KK. Low grade central osteogenic sarcoma. A long-term followup of 20 patients. Clin Orthop Relat Res. 1996 Jan. 198-206. [QxMD MEDLINE Link].

9. Hayashi K, Tsuchiya H, Yamamoto N, Shirai T, Nishida H, Takeuchi A, et al. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases. Int J Clin Oncol. 2014 Aug. 19 (4):731-8. [QxMD MEDLINE Link].

10. Toya M, Yamada Y, Yokoyama R, Taguchi K, Nabeshima K, Isayama T, et al. Dedifferentiated low-grade central osteosarcoma with extensive cystic change initially treated as a simple bone cyst. Pathol Res Pract. 2020 Apr. 216 (4):152832. [QxMD MEDLINE Link].

11. Kurt AM, Unni KK, McLeod RA, Pritchard DJ. Low-grade intraosseous osteosarcoma. Cancer. 1990 Mar 15. 65 (6):1418-28. [QxMD MEDLINE Link].

12. Andresen KJ, Sundaram M, Unni KK, Sim FH. Imaging features of low-grade central osteosarcoma of the long bones and pelvis. Skeletal Radiol. 2004 Jul. 33 (7):373-9. [QxMD MEDLINE Link].

13. King MA, Casarett GW, Weber DA, Burgener FA, O'Mara RE, Wilson GA. A study of irradiated bone. III. Scintigraphic and radiographic detection of radiation-induced osteosarcomas. J Nucl Med. 1980 May. 21 (5):426-31. [QxMD MEDLINE Link]. [Full Text].

14. Olson HM, Capen CC. Intratibial Moloney sarcoma virus-induced osteosarcoma in the rat: tumor incidence and pathologic evaluation. J Natl Cancer Inst. 1977 Feb. 58 (2):433-7. [QxMD MEDLINE Link].

15. Gössner W, Hug O, Luz A, Müller WA. Experimental induction of bone tumors by short-lived bone-seeking radionuclides. Recent Results Cancer Res. 1976. 36-49. [QxMD MEDLINE Link].

16. Hahn FF, Mewhinney JA, Merickel BS, Guilmette RA, Boecker BB, McClellan RO. Primary bone neoplasms in beagle dogs exposed by inhalation to aerosols of plutonium-238 dioxide. J Natl Cancer Inst. 1981 Oct. 67 (4):917-27. [QxMD MEDLINE Link].

17. Enneking WF. Endosteal osteosarcoma. Musculoskeletal Tumor Surgery. New York: Churchill Livingstone; 1983. Vol 2: 1080-90.

18. Ellis JH, Siegel CL, Martel W, Weatherbee L, Dorfman H. Radiologic features of well-differentiated osteosarcoma. AJR Am J Roentgenol. 1988 Oct. 151 (4):739-42. [QxMD MEDLINE Link]. [Full Text].

19. Bertoni F, Bacchini P, Fabbri N, Mercuri M, Picci P, Ruggieri P, et al. Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer. 1993 Jan 15. 71 (2):338-45. [QxMD MEDLINE Link].

20. Campanacci M, Bertoni F, Capanna R, Cervellati C. Central osteosarcoma of low grade malignancy. Ital J Orthop Traumatol. 1981 Apr. 7 (1):71-8. [QxMD MEDLINE Link].

21. Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret A, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011 May. 24(5):624-37. [QxMD MEDLINE Link].

22. Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010 Sep. 23 (9):1279-88. [QxMD MEDLINE Link].

23. Salinas-Souza C, De Andrea C, Bihl M, Kovac M, Pillay N, Forshew T, et al. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas. Mod Pathol. 2015 Oct. 28 (10):1336-42. [QxMD MEDLINE Link].

24. He X, Pang Z, Zhang X, Lan T, Chen H, Chen M, et al. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis. Am J Surg Pathol. 2018 Sep. 42 (9):1143-1155. [QxMD MEDLINE Link].

25. Bone cancer stages. American Cancer Society. Available at https://www.cancer.org/cancer/bone-cancer/detection-diagnosis-staging/staging.html. June 17, 2021; Accessed: November 22, 2021.

26. Osteosarcoma staging. American Cancer Society. Available at https://www.cancer.org/cancer/osteosarcoma/detection-diagnosis-staging/staging.html. October 8, 2020; Accessed: November 22, 2021.

27. Goto T, Okuma T, Nakada I, Hozumi T, Kondo T. [Preoperative adjuvant therapy for primary malignant bone tumors]. Gan To Kagaku Ryoho. 2007 Nov. 34 (11):1750-4. [QxMD MEDLINE Link].

28. Unni KK, Dahlin DC, McLeod RA, Pritchard DJ. Intraosseous well-differentiated osteosarcoma. Cancer. 1977 Sep. 40 (3):1337-47. [QxMD MEDLINE Link].

29. Bielack SS, Hecker-Nolting S, Blattmann C, Kager L. Advances in the management of osteosarcoma. F1000Res. 2016. 5:2767. [QxMD MEDLINE Link]. [Full Text].

30. Han G, Bi WZ, Xu M, Jia JP, Wang Y. Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis. World J Surg. 2016 Aug. 40 (8):2016-27. [QxMD MEDLINE Link].

31. Yang Y, Han L, He Z, Li X, Yang S, Yang J, et al. Advances in limb salvage treatment of osteosarcoma. J Bone Oncol. 2018 Mar. 10:36-40. [QxMD MEDLINE Link].

Barnaby Dedmond, MD Orthopedic Traumatologist, Lexington Orthopedics, Lexington Medical Center

Barnaby Dedmond, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Orthopaedic Surgeons, Orthopaedic Trauma Association

Disclosure: Nothing to disclose.

John Eady, MD Chief of Orthopedic Surgery, Dorn Veterans Affairs Hospital

John Eady, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Orthopaedic Association, Southern Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Harris Gellman, MD Consulting Surgeon, Broward Hand Center; Voluntary Clinical Professor of Orthopedic Surgery and Plastic Surgery, Departments of Orthopedic Surgery and Surgery, University of Miami, Leonard M Miller School of Medicine; Clinical Professor of Surgery, Nova Southeastern School of Medicine

Harris Gellman, MD is a member of the following medical societies: American Academy of Medical Acupuncture, American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Society for Surgery of the Hand, Arkansas Medical Society, Florida Medical Association, Florida Orthopaedic Society

Disclosure: Nothing to disclose.

Timothy A Damron, MD David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse

Timothy A Damron, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Medical Association, Children's Oncology Group, Connective Tissue Oncology Society, Musculoskeletal Tumor Society, Orthopaedic Research Society, Society for Experimental Biology and Medicine

Disclosure: Received research grant from: National Institutes of Health NIAMS; Orthopaedic Research and Education Foundation; Stryker; Cempra; Wright Medical<br/>Received income in an amount equal to or greater than $250 from: Stryker, Inc (Educational travel to Stryker sponsored meetings)<br/>Received royalty from Lippincott, Williams, and Wilkins for editing/writing textbook; Received grant/research funds from Genentech for clinical research; Received grant/research funds from Orthovita for clinical research; Received grant/research funds from National Institutes of Health for clinical research; Received royalty from UpToDate for update preparation author; Received grant/research funds from Wright Medical, Inc. for clinical research.

• Print this section
• Print the entire contents of
• Print the entire contents of article